Translocations or amplifications on top of the genomic alterations by now existing in the initial CLL, but absence the widespread mutations noticed in Principal DLBCL indicating they might correspond to a different biological class. See "Specific therapies in CLL: mechanisms of resistance and methods for administration" on site 471. Duvelisib https://milesy987gwl3.wikijm.com/user